Learn more about a Coombs test and how it is used as part of standard prenatal screening in the U.S. to detect HDFN.

Increased testing for Rh and Kell phenotypes could reduce the risk of adverse transfusion reactions and HDFN, a study found.

FDA grants Fast Track designation to Johnson & Johnson’s investigational therapy nipocalimab for the treatment of moderate-to ...

The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease ...

Spring House, Pennsylvania Wednesday, March 19, 2025, 14:00 Hrs [IST] ...

House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for ...

James Harrison’s rare blood donations saved over 2.4 million babies. His plasma contained Anti-D antibodies, preventing rhesus disease in newborns. Less than 200 Australians donate Anti-D, helping 45, ...

This antibody became crucial in creating a medication that protects unborn babies from a potentially deadly blood disorder called hemolytic disease of the fetus and newborn (HDFN). The condition ...

The injection helps to fight against developing potentially harmful antibodies during pregnancy. Without the injection, Rh(D) positive babies could suffer from fatal Haemolytic Disease of the Fetus ...

James Harrison, who was credited with saving 2.4 million babies through blood plasma donations over six decades, has died at ...

An Australian man credited with saving 2.4 million babies through his record-breaking blood plasma donations over six decades, has died aged 88, his family said on Tuesday. James Harrison, a ...

While it is impossible to know how many babies would have died without Anti-D protection, HDFN affected as many as 1 in 100 women until 1966, government data shows. Following the success of a 1966 ...